BECTON, DICKINSON AND COMPANY Interest Expense Nonoperating
BECTON, DICKINSON AND COMPANY (BDX) reported Interest Expense Nonoperating of $132.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY interest expense nonoperating for the quarter ending 2026-06-30 was $132.00M, a 13.16% decline year-over-year.
- BECTON, DICKINSON AND COMPANY interest expense nonoperating for the quarter ending 2026-03-31 was $149.00M, a 0.67% decline year-over-year.
- BECTON, DICKINSON AND COMPANY interest expense nonoperating for the quarter ending 2025-12-31 was $153.00M, a 1.29% decline year-over-year.
- BECTON, DICKINSON AND COMPANY interest expense nonoperating for the quarter ending 2025-06-30 was $152.00M, a 10.95% increase year-over-year.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month |
|---|---|---|---|---|---|
| 2026-06-30 | $132.00M 10-Q · filed 2026-08-06 | $281.00M derived: sum of 2 quarters · filed 2026-08-06 | $434.00M 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $149.00M 10-Q · filed 2026-05-07 | $302.00M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $153.00M 10-Q · filed 2026-02-09 | ||||
| 2025-06-30 | $152.00M 10-Q · filed 2026-08-06 | $302.00M derived: sum of 2 quarters · filed 2026-08-06 | $458.00M 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $150.00M 10-Q · filed 2026-05-07 | $151.00M 10-Q · filed 2025-05-01 | $305.00M 10-Q · filed 2026-05-07 | $306.00M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $155.00M 10-Q · filed 2026-02-09 | ||||
| 2024-06-30 | $137.00M 10-Q · filed 2025-08-07 | $262.00M derived: sum of 2 quarters · filed 2025-08-07 | $373.00M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $125.00M 10-Q · filed 2025-05-01 | $236.00M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $111.00M 10-Q · filed 2025-02-06 | ||||
| 2023-06-30 | $119.00M 10-Q · filed 2024-08-01 | $339.00M 10-Q · filed 2024-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |